Signals Blog
Menu

Drug giants filling in the Valley of Death

Faced with patent shortages to replace flagship products, Big Pharma is increasing investments in smaller biotech companies to capture innovations early. Most new companies wither and die if they run out of initial funds before they’re profitable.  In biotech,...

If Gandhi were a stem cell, which would he be?

My guess…is an HSC (hematopoietic stem cell). Because although these cells aren’t known for their civil disobedience, they do have a certain knack for making people more tolerant. In fact, that’s why Dr. Megan Sykes, Director of the Columbia Center for Translational...

ISCT meeting: a balance of business and academia that works

With rain, rain and more rain in the forecast, I was more than happy to escape wet and dreary Vancouver and attend the 18th International Society for Cellular Therapy (ISCT) annual meeting, which took place in Seattle, Washington last month. The weather was (slightly)...